Previous 10 | Next 10 |
Phibro Animal Health (NASDAQ:PAHC) and Rejuvenate Bio on Wednesday announced a development and commercialization collaboration for a gene therapy to treat mitral valve disease (MVD) in dogs. MVD is caused due to a problem in the valve between the left heart chambers, which can cause blood to ...
Phibro Animal Health Corporation (Nasdaq:PAHC) and Rejuvenate Bio, Inc. today announced a collaboration for the development and commercialization of a gene therapy for Mitral Valve Disease (MVD) in canines (dogs). The incidence of MVD varies widely but is believed to be present in a...
Phibro Animal Health Corporation (Nasdaq: PAHC), a diversified global developer, manufacturer, and supplier of a broad range of animal health and mineral nutrition products for livestock, published its inaugural Environmental, Social and Governance (ESG) Report (the “Reportȁ...
Phibro Animal Health Corporation (PAHC) Q3 2022 Earnings Conference Call May 05, 2022, 09:00 AM ET Company Participants Damian Finio - CFO Jack Bendheim - Chairman, President and CEO Daniel Bendheim - Director and EVP of Corporate Strategy Conference Call Participants Wolf Chanoff - Bank of A...
Phibro Animal press release (NASDAQ:PAHC): Q3 Non-GAAP EPS of $0.33 misses by $0.02. Revenue of $239.6M (+13.0% Y/Y) beats by $9.07M. Fiscal year 2022 guidance: Net sales of approximately $930 – $950 million, from $890 – $920 million vs. estimates of $911.82M. Adjusted dil...
Phibro Animal Health Corporation (Nasdaq: PAHC) today announced financial results for its third quarter ended March 31, 2022. Highlights for the three months ended March 31, 2022 (compared to the three months ended March 31, 2021) Net sales of $239.6 million, an increase of $2...
Phibro Animal Health Corporation (NASDAQ:PAHC) declares $0.12/share quarterly dividend, in line with previous. Forward yield 2.67% Payable June 22; for shareholders of record June 1; ex-div May 31. For further details see: Phibro Animal Health Corporation declares $0.12 dividend
Phibro Animal Health Corporation (Nasdaq:PAHC) expects to announce its third quarter financial results on Wednesday, May 4, 2022, after the market closes. Phibro management will host a conference call and webcast on Thursday, May 5, 2022, at 9:00 AM Eastern Time. Interested parties ...
The surging demand for animal healthcare products and services has benefited companies operating in this space. Prominent animal healthcare stocks Phibro Animal Health (PAHC) and Zomedica (ZOM) are well-positioned to capitalize on the industry tailwinds. But which of these stocks is a better ...
The following slide deck was published by Phibro Animal Health Corporation in conjunction with their 2022 Q2 earnings call. For further details see: Phibro Animal Health Corporation 2022 Q2 - Results - Earnings Call Presentation
News, Short Squeeze, Breakout and More Instantly...
Phibro Animal Health Corporation Company Name:
PAHC Stock Symbol:
NASDAQ Market:
Phibro Animal Health Corporation Website:
Phibro Animal Health Corporation (Nasdaq: PAHC) proudly announces its third annual Environmental, Social and Governance (ESG) Report, highlighting 2023 achievements. At Phibro, the connections between people, animals and the planet drive us to optimize animal health and nutrition for better lives...
2024-06-04 09:00:27 ET Phibro Animal Health Corp. (PAHC) declaring a stock dividend of $0.12 per share on Ex-Date : June 05, 2024. Shareholders on record as of June 05, 2024 are eligible for the dividend. The payment date is scheduled for June 26, 2024, and the declaration was offic...
2024-05-23 05:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...